Urgent Care Guide 2019 - 2020 - 19

DIAGNOSTICS

Clinicians often have to make immediate clinical
decisions based only on symptoms.1-3 With that in
mind, the ID NOW molecular platform was designed
TM

HOW COULD
RAPID MOLECULAR
ASSAY RESULTS
MAKE A DIFFERENCE?

as a true point-of-care device to improve decisionmaking processes in any setting. More labs and
healthcare professionals are making ID NOW their
rapid molecular platform of choice.4
ID NOW INFLUENZA A & B 2
Results in 13 minutes or less, with
early detection of positives in as littlee
as 5 minutes.5
ID NOW STREP A 2
Results in 6 minutes or less, with
early detection of positives in as littlee
as 2 minutes.5
ID NOW RSV Results in 13 minutes or less.
1. Stein, J. et al. Performance characteristics of clinical diagnosis, a clinical decision rule, and a rapid influenza test in the
detection of influenza infection in a community sample of adults. Annals of Emergency Medicine, 2005; 46(5): 412-9.
2. Mills, J. et al. Rapid testing for respiratory syncytial virus in a paediatric emergency department: Benefits for
infection control and bed management. The Journal of Hospital Infection, 2011: 77(3): 248-51.
3. Cohen, J.F. et al. Rapid antigen detection test for group A streptococcus in children with pharyngitis.
Cochrane Database of Systematic Review, 2013: 5-7. doi: 10.1002/14651858.cd010502.
4. http://www.selectscience.net/products/alere--i-instrument?prodID=203785
5. Clinical Trial Data- Held on File
© 2018 Abbott. All rights reserved. Alere is a trademark of the Abbott group of companies.
All other trademarks referenced are trademarks of their respective owners. 120004423-01 09/18

ID NOW™ Strep A 2

ID NOW™ Molecular
Instrument
ID NOW is a rapid, instrument-based, isothermal
system for the qualitative detection of infectious
diseases. The unique ID NOW isothermal nucleic
acid amplification technology provides molecular
results in just minutes, allowing you to make
effective clinical decisions sooner.
* Small footprint enables ease of use at point of
care
* Simple operation via visual touchscreen
* Requires minimal training
* Connectivity can be provided to your network
#NAT-024, ID NOW Molecular Instrument
(607-0052)........................................................... ea
#EQ00101, ID NOW Barcode Scanner
(607-0054)........................................................... ea
#55115, ID NOW Universal Printer
(607-0053)........................................................... ea
19MS3265

Now the fastest Strep A test without the need
for culture confirmation, the CLIA-waived Alere™
Strep A 2 test provides molecular results in 6
minutes or less on the unique ID NOW platform.
This allows you to confidently test, and with a
positive result, treat, during the patient's visit.
* Early detection: positive results in as few as 2
minutes, with 99% detected within 3 minutes
* Negative results in 6 minutes
* No culture confirmation of negative results
* Nearly 90% fewer false negatives than RADTs
* No incubation time or thermocycling required
* CLIA waived
* Allows for the accurate detection of
group A strep
* Provides the confidence to make clinical
decisions sooner
* Facilitates effective patient management
* Aids targeted antiviral therapy and antimicrobial
stewardship
#734000, ID NOW Strep A 2
(132-5149).................................................... 24/box

ID NOW™ Influenza A & B 2

Delivers molecular flu results in less than 15
minutes on our unique ID NOW platform; making
it significantly faster than other molecular
methods and more accurate than conventional
rapid tests.

ID NOW™ RSV

Molecular. In minutes.™

ID NOW RSV is the first molecular rapid test
to detect RSV in 13 minutes or less, using our
unique ID NOW platform. Traditional laboratory
methods and rapid antigen testing for RSV
diagnoz sis have considerable shortcomings
in terms of turnaround time or performance.
ID NOW RSV allows you to make real-time
clinical decisions that impact patient care.
#435000, ID NOW RSV
(126-8988).................................................... 24/box
* Highly accurate results in 15 minutes
* Specimen types: nasal swab
* Small footprint enables ease of use at
point of care
* Simple operation via visual touchscreen
* CLIA waived
#425-024, ID NOW Influenza A & B 2 Test Kit
(129-8422).................................................... 24/box
#425-080, ID NOW Influenza A & B 2 Control
Swab Kit
(607-0055)........................................................... ea
Log on to www.henryschein.com/medical

Urgent Care Guide 2019 - 2020

Table of Contents for the Digital Edition of Urgent Care Guide 2019 - 2020